GSK Investigational Site

Jamaica, New York 11432

0 studies enrolling now · 5 studies all time

What they study most

Bowel Dysfunction, Constipation, Diabetes Mellitus, Type 2, Neoplasms, Ovarian Cancer, Ovarian Neoplasms, Respiratory Syncytial Virus Infections

Studies at this site

• Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors — Running, not enrolling
• Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above — Completed
• A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens — Completed
• A Study In Patients With Type 2 Diabetes Mellitus — Completed
• Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication — Completed